RT Book, Section A1 Prusiner, Stanley B. A1 Geschwind, Michael A2 Loscalzo, Joseph A2 Fauci, Anthony A2 Kasper, Dennis A2 Hauser, Stephen A2 Longo, Dan A2 Jameson, J. Larry SR Print(0) ID 1190506018 T1 Prion Diseases T2 Harrison's Principles of Internal Medicine, 21e YR 2022 FD 2022 PB McGraw-Hill Education PP New York, NY SN 9781264268504 LK accessmedicine.mhmedical.com/content.aspx?aid=1190506018 RD 2024/04/23 AB Prions are proteins that adopt alternative conformations, which become self-propagating. Some prions cause degeneration of the central nervous system (CNS). Once relegated to causing a group of rare CNS disorders, such as Creutzfeldt-Jakob disease (CJD), increasing evidence argues that prions cause more common neurodegenerative diseases (NDs) including Alzheimer’s disease (AD) and Parkinson’s disease (PD). While CJD is caused by the accumulation of PrPSc prions, recent investigations demonstrate unequivocally that α-synuclein prions cause multiple system atrophy (MSA) (Chap. 440). Infectious MSA prions have been recovered from human brain samples stored in formalin for up to 20 years. Similar resistance to formalin was demonstrated for brain samples from sheep with scrapie. Increasingly, studies show that Aβ and tau prions together cause AD, α-synuclein prions cause both PD and MSA, and tau prions alone cause frontotemporal lobar degeneration (FTLD). In this chapter, we confine our discussion to CJD, which typically presents with a rapidly progressive dementia as well as motor and behavioral abnormalities. The illness is relentlessly progressive and generally causes death within 7 months of onset. Most patients with CJD are between 50 and 75 years of age; however, patients as young as 12 and as old as 96 have been recorded. The role of prions in the pathogenesis of NDs is reviewed in Chap. 424.